Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

U.S. Legislative Update: Takeaways for European Pharma (European Pharmaceutical Review)

Related Content

Delaware Court Awards More Than $180 Million for Breach of Commercially Reasonable Efforts Obligation in Drug Development Milestone Dispute

PTAB’s Reversal Sheds Light on Quantum Computing Patents

Four Steps to Maximize the Value of AI Innovation in Medtech

Five Steps Hotel Owners, Operators, and Management Companies Can Take to Mitigate Risk in the Face of Heightened Antitrust Scrutiny and a Wave of Lawsuits Involving Revenue-Management Tools

Life Sciences Licensing and M&A Update: Catching Up on Recent Decisions Affecting Commercially Reasonable Efforts Definitions and Post-Patent Expiration Royalty Obligations

The Rapid Rise of AI, in Five Charts

U.S. Supreme Court Significantly Curtails SEC Enforcement Forum Discretion

JAMS Releases Mass Arbitration Procedures Following AAA’s Lead

Goodwin Expands Appellate and Supreme Court Litigation Practice with Joe Landry and Cassie Snyder

Best Law Firms 2026 Names Goodwin ERISA Litigation Law Firm of the Year and Recognizes 50 Practice Areas

Goodwin Collects Record $2.7 Billion on M&A, Litigation (Bloomberg Law)

Goodwin Named an Intimidating Opponent in BTI Consulting’s 2026 Most Feared Law Firms in Litigation List

Massachusetts Lawyers Weekly Names Robert Carroll a 2025 Go To Lawyer for Intellectual Property

The Best Lawyers in America 2026 Honors Goodwin Lawyers Nationwide

Delaware Court Awards More Than $180 Million for Breach of Commercially Reasonable Efforts Obligation in Drug Development Milestone Dispute (Westlaw Today)

The Legal 500 US 2025 Recognizes 44 Goodwin Practices and 172 Lawyers

Life Sciences

Litigation

Intellectual Property